Antiretroviral therapy coverage in Belgium
Belgium: Antiretroviral therapy coverage was 88.0% in 2023. ▲ Rising
Antiretroviral therapy coverage in Belgium, 2000–2023
Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of people living with HIV.
Analysis
The most recent figure for antiretroviral therapy coverage in Belgium is 88.0%, measured in 2023.
That represents a change of up 6.0% over ten years.
Over the whole period, antiretroviral therapy coverage in Belgium peaked at 90.0% in 2018 and was at its lowest, 38.0%, in 2000.
Belgium ranks 23rd of 143 countries on this measure, in the top quarter.
The long-run direction has been consistently rising across the 24 years of available data.
Antiretroviral therapy coverage in Belgium, year by year
| Year | % of people living with HIV | Change |
|---|---|---|
| 2000 | 38.0% | — |
| 2001 | 42.0% | +10.5% |
| 2002 | 45.0% | +7.1% |
| 2003 | 48.0% | +6.7% |
| 2004 | 51.0% | +6.2% |
| 2005 | 54.0% | +5.9% |
| 2006 | 63.0% | +16.7% |
| 2007 | 65.0% | +3.2% |
| 2008 | 69.0% | +6.2% |
| 2009 | 73.0% | +5.8% |
| 2010 | 78.0% | +6.8% |
| 2011 | 83.0% | +6.4% |
| 2012 | 80.0% | -3.6% |
| 2013 | 83.0% | +3.8% |
| 2014 | 84.0% | +1.2% |
| 2015 | 87.0% | +3.6% |
| 2016 | 88.0% | +1.1% |
| 2017 | 89.0% | +1.1% |
| 2018 | 90.0% | +1.1% |
| 2019 | 88.0% | -2.2% |
| 2020 | 87.0% | -1.1% |
| 2021 | 88.0% | +1.1% |
| 2022 | 88.0% | +0.0% |
| 2023 | 88.0% | +0.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 54.8% | 38.0% | 73.0% | 10 |
| 2010s | 85.0% | 78.0% | 90.0% | 10 |
| 2020s | 87.8% | 87.0% | 88.0% | 4 |
Countries ranked near Belgium
More health data for Belgium
- Un projection of annual infant deaths, annual growth rate -3.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.2923 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,160 deaths per 1,000 people (2090)
- Number of infants who die before age 1 59 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -2.11 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0229 units per person (2025)
- Population ages 00-04, male, annual growth rate -1.96 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is antiretroviral therapy coverage in Belgium?
- Antiretroviral therapy coverage in Belgium was 88.0% in 2023, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
- What is the highest antiretroviral therapy coverage recorded in Belgium?
- The highest recorded value was 90.0% in 2018.
- What is the lowest antiretroviral therapy coverage recorded in Belgium?
- The lowest recorded value was 38.0% in 2000.
- How does Belgium rank for antiretroviral therapy coverage?
- Belgium ranks 23rd out of 143 countries with data for 2023.
- Is antiretroviral therapy coverage rising or falling in Belgium?
- Over the last ten years it is up 6.0%. The long-run trend across the full record is rising.
- Where does this Belgium data come from?
- The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage (% of people living with HIV). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy.